To amend title XVIII of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicare program.
Requires Medicare to cover lung cancer biomarker testing to guide treatment, improving access and reducing cost barriers for beneficiaries and enabling personalized therapy.